Revolution Medicines, Inc. (RVMD)
142.10
-3.56
(-2.44%)
USD |
NASDAQ |
May 18, 12:01
Revolution Medicines Research and Development Expense (Quarterly) : 341.62M for March 31, 2026
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| Tango Therapeutics, Inc. | 33.07M |
| Insmed, Inc. | 209.48M |
| Erasca, Inc. | 27.26M |
| Travere Therapeutics, Inc. | 57.09M |
| Spyre Therapeutics, Inc. | 60.41M |